Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Monthly Archives: October 2013

Dispute over the names for biosimilars

Posted in Pharmaceutical Advertising

As reported by DrugStoreNews.com, there has been a lot of discussion in the biotechnology world over the appropriate names of follow-on biologics.  “Follow-on biologics,” also known as “biosimilars,” are “biologic medical products whose active drug substance is made by a living organism or derived from a living organism by means of recombinant DNA or controlled gene… Continue Reading

Forbes: Obamacare Disincentives Medical Innovation

Posted in Politics

A recent article published by Forbes.com purports that Obamacare is harming the American healthcare system.  While the healthcare system we had before the Affordable Care Act was not perfect, it was more fundamentally sound than after the ACA took effect.  Problems with U.S. Health Care System should have been closely examined in 2009 and appropriate… Continue Reading

Maine Passes Law Allowing Importation of Potentially Fake Pharmaceuticals

Posted in Politics, Public Health

The wide range of tools the internet can provide has proven problematic in the regulation of prescription drugs that are sold from online pharmaceutical companies based in foreign countries.  Counterfeit drugs have exploded onto the scene and as reported by Forbes, the worldwide market for these drugs is estimated to be worth 75 billion dollars…. Continue Reading

2006 – Research finds 14.6% of men require secondary surgery following penile prosthesis implantation

Posted in Penile Implants

We are no longer accepting cases regarding these products.  Due to a terrible Supreme Court ruling, consumers injured by this product are no longer permitted to sue the manufacturers of this device.  We wish we could help, but the Supreme Court has taken the rights of citizens away to protect the profits of medical device… Continue Reading

1995 – Pancreatitis found associated with pancreatic cancer

Posted in Byetta, GLP-1 Diabetes Drugs, Januvia, Victoza

Author P. Bansal from the Division of Gastroenterology at the Department of Veterans Affairs Medical Center in Milwaukee, Wisconsin, conducted a study called “Pancreatitis is a Risk Factor For Pancreatic Cancer”, where the main goal was to determine if pancreatitis is a risk factor for pancreatic cancer.  Information for this study was obtained from the… Continue Reading

2004 – Research Connects Pancreatitis and Pancreatic Cancer

Posted in Byetta, GLP-1 Diabetes Drugs, Januvia, Victoza

Recent studies have shown that there is a positive correlation between pancreatic inflammation and an increased risk of pancreatic cancer.  While acute pancreatitis that appears suddenly and may last for only a few days may not put an individual at a higher risk for cancer, chronic pancreatitis may last for several years and is associated… Continue Reading

Trade Groups Fight Drug Recycling Program Regulations in San Francisco Bay Area

Posted in Politics

A recent article by Eric Palmer of the pharmaceutical news website FiercePharmaManufacturing.com writes that some trade groups, including PhRMA are trying to overturn a law passed unanimously in Alameda County, California that requires pharmaceutical manufacturers to pay for a medication “recycling” program for currently in place in the San Francisco Bay area. As the law… Continue Reading

Boston Salads Recall for Listeria Contamination

Posted in Public Health

Due to a possible contamination with Listeria monocytogenes, Boston Salads and Provisions Company is recalling 222,959 pounds of ready to eat chicken salad products.  As reported by FoodSafetyNews.com, the contaminaited chcken salad prodcuts in question were made August 23rd, 2013 to October 14th, 2013 and were shipped to wholesalers in Massachusetts and New Hampshire.  Despite… Continue Reading

New Cancer Drug Ramucirumab (Eli Lilly & Co.) Prioritized by FDA

Posted in Drug Studies

Headquartered in Indianapolis, Indiana, Eli Lilly and Company is a pharmaceutical company with offices all over the world.  Recently, the company developed a single-agent treatment for gastric cancer; a drug called Ramucirumab.  Ramucirumab is used if cancer continues to progress after initial chemotherapy.  And according to a report published 10-24-2013 by PharmaceuticalBusinessReview.com, the company recently… Continue Reading

2011 – Pancreatitis, Pancreatic, and Thyroid Cancer Associated with GLP-1 Therapy Drugs

Posted in Byetta, GLP-1 Diabetes Drugs, Januvia, Victoza

In 2011, M. Elashoff, from the Larry L. Hillblom Islet Research Center at David Geffen School of Medicine and Department of Biomathematics at University of California, Los Angeles, published a study titled “Pancreatitis, Pancreatic, and Thyroid Cancer with Glucagon like Peptide-1-based Therapies”, wherein concerns regarding risk for pancreatitis and pancreatic and thyroid cancers are explored…. Continue Reading

2006 – Neonatal Abstinence Syndrome Seen in Children Exposed to SSRIs in Pregnancy

Posted in Celexa Birth Defects, Effexor Birth Defects, Paxil Birth Defects, Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

The objective of a study titled “Neonatal Abstinence Syndrome After in Utero Exposure to Selective Serotonin Reuptake inhibitors in Term Infants”, written by researchers from the Neonatal Intensive Care Unit at Schneider Children’s Medical Center of Israel, led by R. Levinson-Castiel was to determine the prevalence and clinical characteristics of neonatal abstinence syndrome in neonates… Continue Reading

2013 – Study links Byetta, Victoza, Januvia to pancreatitis, pancreatic cancer

Posted in Byetta, GLP-1 Diabetes Drugs, Januvia, Victoza

Studies have shown that pancreatitis is associated with the use of exenatide (Byetta, Bydureon), liraglutide (Victoza), and sitagliptin (Januvia, Janumet, Janumet XR, Juvisync) and other glucagon like peptide 1 (GLP-1) receptor agonists.  The pancreatitis associated with these therapies and medications may increase the risks for pancreatic cancer.  Experiments done on mice and rats have shown… Continue Reading

2005 – Cipro found associated with serious CNS side effects

Posted in Cipro

Quinilones are synthetic antibacterial drugs used for the treatment of urinary tract infections.  Quinilones are effective in the fight against bacteria because they prevent bacterial DNA from unwinding and multiplying.  This unwinding and duplicating process is how bacteria spread and infect different parts of the body.  Quinolones in the clinical setting belong to the subset… Continue Reading

2009 – Zoloft use during pregnancy raises risk for septal heart defects 3-fold

Posted in SSRI Birth Defects, Zoloft Birth Defects

The objective of a study done titled “Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study” by  LH. Pedersen from the Department of Epidemiology, Institute of Public Health, Aarhus University, was to take a closer look between selective serotonin reuptake inhibitors taken during pregnancy and their ability to cause major congenital… Continue Reading

Maternal use of Effexor, other SSRIs may result in neonatal abstinence syndrome

Posted in Celexa Birth Defects, Effexor Birth Defects, Paxil Birth Defects, Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

A study conducted by the Department of Psychological Medicine, King Edward Memorial Hospital for Women, Subiaco, Australia, titled “Placental Transfer of SSRI and SNRI Antidepressants and Effects On The Neonate”, investigated placental transfer and neurobehavioural effects in neonates exposed to venlafaxine (Effexor), sertraline (Zoloft), paroxetine (Paxil), fluvoxamine, fluoxetine (Prozac), escitalopram, and citalopram (Celexa).  The neonates… Continue Reading

2011 – Research links use of Celexa, other SSRIs and childhood autism

Posted in Celexa Birth Defects, Prozac Birth Defects, SSRI Birth Defects

A team of medical researchers led by F. Rodriguez-Porcel (2011), from the Department of Psychiatry & Human Behavior at The University of Mississippi Medical Center in Jackson, conducted a study titled “Neonatal Exposure of Rats to Antidepressants Affects Behavioral Reactions to Novelty and Social Interactions in a Manner Analogous to Autistic Spectrum Disroders”, where it… Continue Reading

2005 – Study finds Paxil associated with neonatal withdrawal syndrome

Posted in Paxil Birth Defects, SSRI Birth Defects

There is an ongoing debate in the medical community whether or not selective serotonin reuptake inhibitors have fetus damaging capabilities and can cause major congenital malformations for exposed offspring in utero.  There has been strong evidence that selective serotonin inhibitors have been associated with withdrawal symptoms.  A recent study published by researchers from University of… Continue Reading

2006 – Paxil associated with neonatal withdrawal syndrome

Posted in Paxil Birth Defects, SSRI Birth Defects

Depression in pregnant women has been known to increase the likelihood of fetal malformations.  As such, antidepressants like selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed to pregnant women suffering from depression.  The effects of SSRI’s on fetal development has been studied extensively to see if the use of SSRI’s puts the fetus at risk… Continue Reading

2004 – Doctors Avoid SSRIs in Pregnant Women

Posted in Celexa Birth Defects, Effexor Birth Defects, Paxil Birth Defects, Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

The objective of a study published by researchers from the OMNI Research Group within the Department of Obstetrics and Gynaecology at The University of Ottawa, in Ottawa ON, titled “The Use of Selective Serotonin Reuptake Inhibitors in Pregnancy”, was to update literature on the safety of using selective serotonin reuptake inhibitors during pregnancy. For this… Continue Reading

Salmonella Outbreak in California

Posted in Public Health, Safety Alerts

On October 11th, the US Centers for Disease Control and Prevention reported that 317 people have become sick across the country in a recent outbreak of salmonella “tied to a California poultry producer.”  As reported by the American Association for Justice, “nearly half of the cases required hospitalization” and about three-quarters of the cases have… Continue Reading

2013 – CDC: Salmonella Outbreak Sickens 317 in 20 States

Posted in Public Health, Safety Alerts

On October 11th, the US Centers for Disease Control and Prevention reported that 317 people have become sick across the country in a recent outbreak of salmonella “tied to a California poultry producer.”  As reported by the American Association for Justice, “nearly half of the cases required hospitalization” and about three-quarters of the cases have… Continue Reading